FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
about
Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesisA shear stress responsive gene product PP1201 protects against Fas-mediated apoptosis by reducing Fas expression on the cell surfaceTranscriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicityThe role of CD95 and CD95 ligand in cancerCaspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response.Caspase cleavage of the Golgi stacking factor GRASP65 is required for Fas/CD95-mediated apoptosis.FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activationmiR-200c regulates induction of apoptosis through CD95 by targeting FAP-1Protein tyrosine phosphatases as potential therapeutic targets.3-O-sulfated heparan sulfate recognized by the antibody HS4C3 contributes [corrected] to the differentiation of mouse embryonic stem cells via fas signalingPigment epithelial-derived factor (PEDF)-triggered lung cancer cell apoptosis relies on p53 protein-driven Fas ligand (Fas-L) up-regulation and Fas protein cell surface translocation.Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanismOpposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosisSequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway.FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target.Broad targeting of resistance to apoptosis in cancer.Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95PTPL1: a large phosphatase with a split personality.Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells.Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1.Protein tyrosine phosphatases in glioma biologyPTPN13/PTPL1: an important regulator of tumor aggressiveness.Targeting the Fas/FasL signaling pathway in cancer therapy.The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells.DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation.Gene expression changes in long-term culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence.The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors.CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF.Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activation.Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.MiR-200c regulates ROS-induced apoptosis in murine BV-2 cells by targeting FAP-1.The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).The impact of phosphatases on proliferative and survival signaling in cancer.
P2860
Q24296214-0AC29956-368C-40B6-B2E1-C6DCFF6E061AQ24302108-55C21C10-AB1E-4B3F-AEB6-E6A8046F52F6Q24309054-BBAB74B6-5261-4DCC-BFFD-CB29008D1C43Q24633850-51C592F7-2FF1-4B67-86C2-3DA4F9B3273BQ26995847-7BDA4569-C389-432A-866A-BD822BFC36C0Q30479002-DA003982-D129-49C0-911F-D8B4066B216BQ30498132-4D5F5E21-DA2F-42F3-ACBD-D3B9D6B25187Q33837045-7A20F77E-39D0-4C3A-A0EF-85FCE316A23DQ33996050-11B23153-EEE3-4EF9-AD8F-5CE28885C988Q34295063-D8C971A7-D39D-48F1-866C-1D92E34E4052Q34391600-8DE5803C-A623-4479-BE62-6CFF204E72DFQ34431110-04FC1603-9D03-4A09-822D-A38CF99EB357Q35088374-337AAE03-7A79-45C8-A52A-AC76ED35826AQ35223578-A0A0F923-3EB3-4347-976A-7EBDF734B764Q35229797-F3166FB7-A3F7-4979-B500-D49E268E38F7Q35320386-8C4D90B8-C4C0-4962-A186-19846DCFABC4Q36352352-6BD8D509-B99C-4AE9-92F3-A5E5BF134F86Q36483749-E13CD3E1-FC91-4BC7-A45A-16C6FF4CA8DFQ36782452-83F3697D-B333-4E87-95E8-6E6AA1F23834Q37081432-1459F203-6310-4B3D-84AD-3849E8438961Q37346528-420FE0EE-1822-4BD3-A9A9-90DA286F3BD6Q37420801-C7A63FE8-71C8-406E-B37A-B9D1FB5B8848Q37638344-7704B353-343B-4BFE-BA6F-23FC65E5908EQ37828546-66883C85-6396-4E20-A734-381B211A1A7EQ37975245-0CDFF502-9F7F-441F-AFD9-F73C9E34DDBEQ38294534-4A9C6DC1-F00D-44EA-9E80-1149A7CB3F11Q38296215-717D5B13-D4FF-4F7F-96B2-6FF6DCCFDBD1Q38877894-14BAE37F-2B7F-46A2-B807-C61CA8ED34FAQ39253570-E1636BB2-2F96-43E2-B093-CEAAB84D9A50Q39650793-34FE321A-7E1D-407D-982B-B2BB0E990299Q39789584-76F0A833-DAF4-4AF9-8F5C-66BF2EECA267Q40076969-AC6DC97D-3D25-4327-BDE0-698A4D9FDC56Q40255312-49FAC287-BB7C-4A94-AC15-4B73DAF88B85Q40314772-79DC78F7-212E-466D-B26F-8C59821355B6Q40403108-DC968F30-9AF0-42CE-AFB1-24BDEA192DE5Q41757730-BD06CF91-4853-4F75-9899-FB506486DA98Q42131985-3540AFCF-54B1-49BD-928A-FEA459692F5DQ54112403-1E78F1B5-39D7-4327-A10A-495B2DAA61C5
P2860
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@ast
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@en
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@en-gb
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@nl
type
label
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@ast
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@en
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@en-gb
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@nl
prefLabel
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@ast
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@en
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@en-gb
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@nl
P2093
P2860
P1476
FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface
@en
P2093
Gabriel Maulit
Pablo Lopez Bergami
Taka-Aki Sato
Vladimir N Ivanov
P2860
P304
P356
10.1128/MCB.23.10.3623-3635.2003
P407
P577
2003-05-01T00:00:00Z